share_log

和鉑醫藥-B：股東週年大會通告

HBM HOLDINGS-B: NOTICE OF ANNUAL GENERAL MEETING

Hong Kong Stock Exchange ·  Apr 24 19:23
Summary by Moomoo AI
和鉑醫藥-B將於2024年6月6日舉行股東週年大會，地點為中國上海自由貿易試驗區。會議將審議多項議案，包括採納截至2023年12月31日的經審核財務報表、董事會報告與核數師報告，以及重選王勁松博士、戎一平博士和Albert R.Collinson博士為公司董事。此外，會議還將授權董事會釐定董事酬金，續聘安永會計師事務所為核數師並釐定其酬金。股東大會還將考慮授權董事在未來一年內發行新股份或回購股份，並在回購股份後擴大發行新股份的一般授權。所有決議案將以投票方式進行表決，股東有權委任代表出席及投票。公司將於6月3日至6月6日暫停股份過戶登記，以釐定出席大會的股東名單。
和鉑醫藥-B將於2024年6月6日舉行股東週年大會，地點為中國上海自由貿易試驗區。會議將審議多項議案，包括採納截至2023年12月31日的經審核財務報表、董事會報告與核數師報告，以及重選王勁松博士、戎一平博士和Albert R.Collinson博士為公司董事。此外，會議還將授權董事會釐定董事酬金，續聘安永會計師事務所為核數師並釐定其酬金。股東大會還將考慮授權董事在未來一年內發行新股份或回購股份，並在回購股份後擴大發行新股份的一般授權。所有決議案將以投票方式進行表決，股東有權委任代表出席及投票。公司將於6月3日至6月6日暫停股份過戶登記，以釐定出席大會的股東名單。
AND PLATINUM PHARMACEUTICAL-B WILL HOLD ITS ANNUAL GENERAL MEETING ON JUNE 6, 2024 AT THE SITE OF SHANGHAI FREE TRADE TRIAL ZONE, CHINA. The meeting will consider a number of motions, including the adoption of audited financial statements as of December 31, 2023, the Board's Report and Auditor's Report, and the re-election of Dr. Wang Jinsong, Dr. Jung Yi Ping and Dr. Albert R. Collinson as directors of the Company. IN ADDITION, THE MEETING WILL AUTHORIZE THE BOARD TO DETERMINE THE REMUNERATION OF THE DIRECTORS, TO RENEW AND DETERMINE THE REMUNERATION OF EY ACCOUNTANTS AS AUDITORS. The General Meeting will also consider authorizing the directors to issue new shares or repurchase shares over the next year and to extend the...Show More
AND PLATINUM PHARMACEUTICAL-B WILL HOLD ITS ANNUAL GENERAL MEETING ON JUNE 6, 2024 AT THE SITE OF SHANGHAI FREE TRADE TRIAL ZONE, CHINA. The meeting will consider a number of motions, including the adoption of audited financial statements as of December 31, 2023, the Board's Report and Auditor's Report, and the re-election of Dr. Wang Jinsong, Dr. Jung Yi Ping and Dr. Albert R. Collinson as directors of the Company. IN ADDITION, THE MEETING WILL AUTHORIZE THE BOARD TO DETERMINE THE REMUNERATION OF THE DIRECTORS, TO RENEW AND DETERMINE THE REMUNERATION OF EY ACCOUNTANTS AS AUDITORS. The General Meeting will also consider authorizing the directors to issue new shares or repurchase shares over the next year and to extend the general mandate to issue new shares after the repurchase. All resolutions will be put to the vote by vote, with shareholders having the right to appoint representatives to attend and vote. The Company will suspend the registration of shares from 3 June to 6 June in order to determine the list of shareholders to attend the General Meeting.

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more